NEW YORK, Dec. 8, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Merck KGaA: PharmaVitae Profile
http://www.reportlinker.com/p0186215/Merck-KGaA-PharmaVitae-Profile.html
Introduction
This analysis examines the historical and forecast performance for Merck KGaA in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.
Features and benefits
Gain insight into Merck KGaA's strategic outlook across the next 6 years
Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source
Highlights
Strategic insight into the prospects for Merck KGaA over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
Your key questions answered
Benchmark Merck KGaA's performance against key rivals in the prescription pharmaceutical sector
See how Erbitux and six new launches will drive the company's sales growth
Assess the effects of Millipore on the company's non-prescription pharmaceutical sales
To order this report:
: Merck KGaA: PharmaVitae Profile
Check our Company Profile, SWOT and Revenue Analysis!
SOURCE Reportlinker